Thalachallour Mohanakumar: Difference between revisions
Content deleted Content added
m Dating maintenance tags: {{Cn}} |
Added wikilinks; removed dead-end tag |
||
| Line 1: | Line 1: | ||
{{Multiple issues| |
{{Multiple issues| |
||
{{dead end|date=December 2017}} |
|||
{{orphan|date=December 2017}} |
{{orphan|date=December 2017}} |
||
{{third party|date=December 2017}} |
{{third party|date=December 2017}} |
||
}} |
}} |
||
'''Thalachallour Mahonakumar''' is an Indian academic and professor with a research interest in tumor immunology for lung/breast cancer and bone marrow transplantation.<ref>{{Cite news|url=https://siteman.wustl.edu/doctor/mohanakumar-thalachallour-phd/|title=Mohanakumar, Thalachallour, PhD - Siteman Cancer Center|work=Siteman Cancer Center|access-date=2017-10-12|language=en-US}}</ref> His academic title is the Jacqueline G. and William E. Maritz professor of Surgery, Pathology, and Immunology in the Department of Surgery at Washington University School of Medicine. |
'''Thalachallour Mahonakumar''' is an Indian academic and professor with a research interest in [[Cancer immunology|tumor immunology]] for lung/breast cancer and bone marrow transplantation.<ref>{{Cite news|url=https://siteman.wustl.edu/doctor/mohanakumar-thalachallour-phd/|title=Mohanakumar, Thalachallour, PhD - Siteman Cancer Center|work=Siteman Cancer Center|access-date=2017-10-12|language=en-US}}</ref> His academic title is the Jacqueline G. and William E. Maritz professor of Surgery, Pathology, and Immunology in the Department of Surgery at [[Washington University School of Medicine]]. |
||
From India, Mohanakumar's prior education includes a doctorate of veterinary medicine at Madras Veterinary College, a master’s degree in microbiology from All-India Institute of Medical Sciences in New Delhi, and a PhD in immunology at Duke University.<ref>{{Cite news|url=https://source.wustl.edu/2013/12/mohanakumar-receives-clinical-science-award/|title=Mohanakumar receives clinical science award {{!}} The Source {{!}} Washington University in St. Louis|date=2013-12-11|work=The Source|access-date=2017-10-12|language=en-US}}</ref> |
From India, Mohanakumar's prior education includes a doctorate of veterinary medicine at [[Madras Veterinary College]], a master’s degree in microbiology from [[All-India Institute of Medical Sciences]] in New Delhi, and a PhD in immunology at [[Duke University]].<ref>{{Cite news|url=https://source.wustl.edu/2013/12/mohanakumar-receives-clinical-science-award/|title=Mohanakumar receives clinical science award {{!}} The Source {{!}} Washington University in St. Louis|date=2013-12-11|work=The Source|access-date=2017-10-12|language=en-US}}</ref> |
||
During his time at Washington University, Mahonakumar has made numerous contributions in his success of clinical and research programs, including the immunological mechanisms underlying transplant rejection. Along with heading transplant programs, he also supervises islet location and is the Director of Histocompatibility, an important component of bone marrow and organ transplantation. He has received accomplishments, awards, and citations from the American Society of Histocompatibility and Immunogenetics, American Society of Transplantation, and the Juvenile Diabetes Research Foundation.{{cn|date=December 2017}} In his research, he has published more than 350 manuscripts and has served on many National Institutes of Health (NIH) study sections.<ref>{{Cite news|url=https://medicine.wustl.edu/news/about/faculty-recognition/distinguished-faculty-awards/2010-2/thalachallour-mohanakumar-phd/|title=Thalachallour Mohanakumar, PhD {{!}} Washington University School of Medicine in St. Louis|work=Washington University School of Medicine in St. Louis|access-date=2017-10-12|language=en-US}}</ref> Mahonakumar and his research group have been studying the processes of lung transplant rejection for more than 20 years. Recently, they found a possible diagnosis for chronic lung allograft dysfunction (CLAD) by monitoring proteins, such as Zinc finger and BYB domain-containing protein 7A (ZBTB7A).<ref>{{Cite news|url=https://medicalxpress.com/news/2017-07-indicator-lung-transplant.html|title=Researchers discover indicator of lung transplant rejection|access-date=2017-10-12}}</ref> |
During his time at Washington University, Mahonakumar has made numerous contributions in his success of clinical and research programs, including the immunological mechanisms underlying [[transplant rejection]]. Along with heading transplant programs, he also supervises [[islet]] location and is the Director of [[Histocompatibility]], an important component of bone marrow and organ transplantation. He has received accomplishments, awards, and citations from the American Society of Histocompatibility and Immunogenetics, [[American Society of Transplantation]], and the [[Juvenile Diabetes Research Foundation]].{{cn|date=December 2017}} In his research, he has published more than 350 manuscripts and has served on many [[National Institutes of Health]] (NIH) study sections.<ref>{{Cite news|url=https://medicine.wustl.edu/news/about/faculty-recognition/distinguished-faculty-awards/2010-2/thalachallour-mohanakumar-phd/|title=Thalachallour Mohanakumar, PhD {{!}} Washington University School of Medicine in St. Louis|work=Washington University School of Medicine in St. Louis|access-date=2017-10-12|language=en-US}}</ref> Mahonakumar and his research group have been studying the processes of lung transplant rejection for more than 20 years. Recently, they found a possible diagnosis for chronic lung [[Allotransplantation|allograft]] dysfunction (CLAD) by monitoring proteins, such as Zinc finger and BYB domain-containing protein 7A (ZBTB7A).<ref>{{Cite news|url=https://medicalxpress.com/news/2017-07-indicator-lung-transplant.html|title=Researchers discover indicator of lung transplant rejection|access-date=2017-10-12}}</ref> |
||
==References== |
==References== |
||
Revision as of 00:49, 1 January 2018
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Thalachallour Mahonakumar is an Indian academic and professor with a research interest in tumor immunology for lung/breast cancer and bone marrow transplantation.[1] His academic title is the Jacqueline G. and William E. Maritz professor of Surgery, Pathology, and Immunology in the Department of Surgery at Washington University School of Medicine.
From India, Mohanakumar's prior education includes a doctorate of veterinary medicine at Madras Veterinary College, a master’s degree in microbiology from All-India Institute of Medical Sciences in New Delhi, and a PhD in immunology at Duke University.[2]
During his time at Washington University, Mahonakumar has made numerous contributions in his success of clinical and research programs, including the immunological mechanisms underlying transplant rejection. Along with heading transplant programs, he also supervises islet location and is the Director of Histocompatibility, an important component of bone marrow and organ transplantation. He has received accomplishments, awards, and citations from the American Society of Histocompatibility and Immunogenetics, American Society of Transplantation, and the Juvenile Diabetes Research Foundation.[citation needed] In his research, he has published more than 350 manuscripts and has served on many National Institutes of Health (NIH) study sections.[3] Mahonakumar and his research group have been studying the processes of lung transplant rejection for more than 20 years. Recently, they found a possible diagnosis for chronic lung allograft dysfunction (CLAD) by monitoring proteins, such as Zinc finger and BYB domain-containing protein 7A (ZBTB7A).[4]
References
- ^ "Mohanakumar, Thalachallour, PhD - Siteman Cancer Center". Siteman Cancer Center. Retrieved 2017-10-12.
- ^ "Mohanakumar receives clinical science award | The Source | Washington University in St. Louis". The Source. 2013-12-11. Retrieved 2017-10-12.
- ^ "Thalachallour Mohanakumar, PhD | Washington University School of Medicine in St. Louis". Washington University School of Medicine in St. Louis. Retrieved 2017-10-12.
- ^ "Researchers discover indicator of lung transplant rejection". Retrieved 2017-10-12.
 | This article needs additional or more specific categories. (December 2017) |